Classification of idiopathic inflammatory myopathies

Key Points

• Distinct subtypes of idiopathic inflammatory myopathies exist, improving diagnosis and treatment options.
• The study identified several key biomarkers that differentiate between the myopathy subtypes.
• Assessment using clinical criteria and biomarkers establishes a robust framework for classifying these conditions.
• Highlights the need for collaboration in future studies to refine classification methods across diverse populations.